Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Oncotarget
|
December 10, 2017
The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-<i>O</i>-phosphate
Joanna Shepherd, Matthew Fisher, Abigail Welford, et al.
Biomedical Optics Express
|
October 31, 2017
Vascular patterning of subcutaneous mouse fibrosarcomas expressing individual VEGF isoforms can be differentiated using angiographic optical coherence tomography
Robert A Byers, Matthew Fisher, Nicola J Brown, et al.
Journal of Clinical Anesthesia
|
June 20, 2017
Scheduling non-operating room anesthesia cases in endoscopy: Using the sandbox analogy
Mitchell H Tsai, Leah A Cipri, Stephen E O'Donnell, et al.
BMJ Open
|
October 6, 2018
Qualitative protocol for understanding the contribution of Australian policy in the urban planning, justice, energy and environment sectors to promoting health and health equity
Fran Baum, Toni Delany-Crowe, Matthew Fisher, et al.
Plos One
|
May 9, 2012
Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale
Sheila Harris, Madeleine Craze, Jillian Newton, et al.
Chemmedchem
|
October 4, 2018
Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy
Andrew W Brown, Toby Holmes, Matthew Fisher, et al.
Journal of Biomechanical Engineering
|
March 12, 2026
An Exploratory Assessment of Associations Between Serum Estrogen to Progesterone Ratio and Anterior Cruciate Ligament Size, Biomechanics, and T2* Relaxation Time in the Porcine Model
Jacob Thompson, Danielle Howe, Emily Griffith, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals
|
September 12, 2021
Barriers to digital health services among people living in areas of socioeconomic disadvantage: Research from hospital diabetes and antenatal clinics
Toby Freeman, Matthew Fisher, Kristen Foley, et al.
Medical Engineering & Physics
|
October 12, 2010
Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents
Simon Akerman, Constantino Carlos Reyes-Aldasoro, Matthew Fisher, et al.
Plos One
|
June 21, 2018
ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo
Darren L Lath, Clive H Buckle, Holly R Evans, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Oncotarget
|
December 10, 2017
The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-<i>O</i>-phosphate
Joanna Shepherd, Matthew Fisher, Abigail Welford, et al.
Biomedical Optics Express
|
October 31, 2017
Vascular patterning of subcutaneous mouse fibrosarcomas expressing individual VEGF isoforms can be differentiated using angiographic optical coherence tomography
Robert A Byers, Matthew Fisher, Nicola J Brown, et al.
Journal of Clinical Anesthesia
|
June 20, 2017
Scheduling non-operating room anesthesia cases in endoscopy: Using the sandbox analogy
Mitchell H Tsai, Leah A Cipri, Stephen E O'Donnell, et al.
BMJ Open
|
October 6, 2018
Qualitative protocol for understanding the contribution of Australian policy in the urban planning, justice, energy and environment sectors to promoting health and health equity
Fran Baum, Toni Delany-Crowe, Matthew Fisher, et al.
Plos One
|
May 9, 2012
Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale
Sheila Harris, Madeleine Craze, Jillian Newton, et al.
Chemmedchem
|
October 4, 2018
Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy
Andrew W Brown, Toby Holmes, Matthew Fisher, et al.
Journal of Biomechanical Engineering
|
March 12, 2026
An Exploratory Assessment of Associations Between Serum Estrogen to Progesterone Ratio and Anterior Cruciate Ligament Size, Biomechanics, and T2* Relaxation Time in the Porcine Model
Jacob Thompson, Danielle Howe, Emily Griffith, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals
|
September 12, 2021
Barriers to digital health services among people living in areas of socioeconomic disadvantage: Research from hospital diabetes and antenatal clinics
Toby Freeman, Matthew Fisher, Kristen Foley, et al.
Medical Engineering & Physics
|
October 12, 2010
Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents
Simon Akerman, Constantino Carlos Reyes-Aldasoro, Matthew Fisher, et al.
Plos One
|
June 21, 2018
ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo
Darren L Lath, Clive H Buckle, Holly R Evans, et al.
Page
of 7